Intracranial Pressure Monitoring Devices Market to Witness Massive Expansion as Incidence of Traumatic Brain Injuries and Neurodegenerative Disorders Continues to Increase

 

Intracranial pressure (ICP) monitoring refers to a diagnostic test, which uses a device that helps doctors to determine cerebrospinal fluid (CSF) pressure is whether low or high. The monitor senses the pressure inside the skull and sends measurements to the recording device. ICP monitoring devices are typically used to examine brain trauma and head injuries. It is also used to examine neurodegenerative disorders such as Parkinson’s and Alzheimer's.

Increasing cases of head and brain injuries are expected to drive growth of the global intracranial pressure monitoring devices market during the forecast period. According to the Centers for Diseases Control and Prevention (CDC), traumatic brain injury (TBI), is one of the major causes of death and disability in the U.S. According to the same source, from 2006 to 2014, TBI-associated hospitalization and deaths increased by 53%, whilst around 155 people die each year from TBI-related injuries in the U.S. According to the CENTER-TBI, around 50 million new cases of TBI are recorded globally, while around 57,000 TBI-related deaths are recorded in the European Union (EU). Such a massive incidence of TBI has led to high demand for intracranial pressure monitoring devices. These devices enable doctors to determine if the cerebrospinal fluid is high or low. Thus, these factors are expected to drive growth of the global intracranial pressure monitoring devices market during the forecast period. Moreover, rising prevalence of neurodegenerative disorders is expected to boost the global intracranial pressure monitoring devices market growth over the forecast period. According to the Alzheimer’s Association, over 5 million U.S. citizens of all ages suffer from Alzheimer’s, a neurodegenerative disorder.

However, the lack of skilled personnel for handling equipment combined with high procedural cost of these devices is expected to restrain growth of the global intracranial pressure monitoring devices market growth over the forecast period. Besides, growing awareness and technological advancements in intracranial pressure monitoring devices can present lucrative growth opportunities in the near future. Among regions, North America is expected to witness significant growth in the global intracranial pressure monitoring devices market during the forecast period. This is owing to the presence of robust healthcare infrastructure and early adoption of advanced ICP monitoring devices across the region. Moreover, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to proactive initiatives undertaken by government authorities and the presence of well-established hospitals in the region.

Key companies involved in the global intracranial pressure monitoring devices market are Medtronic plc, Natus Medical Incorporated, Codman & Shurtleff Inc., Spiegelberg GmbH & Co. KG, RAUMEDIC AG, Integra LifeSciences Corporation, Sophysa Ltd, and Orsan Medical Technologies.

For instance, in April 2019, Integra LifeSciences Corporation introduced the new Codman Specialty Surgical Product CereLink Intracranial Pressure (ICP) Monitoring System.